You’re unique, your products should be too

SHOP H2BAR BEAUTY PRODUCTS
Skin

Break Up With Your Makeup Redhead Selfies Galore – You Could Win $500!

Redheads typically have very fair, sensitive skin and many suffer from unruly skin. Did you know that redness, bumps and pimples on your face aren’t necessarily a sign of acne? They could also be an indication that you are suffering from the common, yet often misunderstood, skin condition rosacea.

We were overjoyed to recently share the Break Up With Your Makeup program with you. It’s an awesome initiative empowering those with rosacea, or those who struggle with redness, bumps and pimples, to share a no makeup selfie and show how you stay confident even on “tough skin days.”

The contest entry portion of the program is now closed – sending lucky vibes to all who participated! But here’s the great news – from now through August 14th you can still win big. We invite all How to be a Redhead readers to visit the gallery page and vote for your favorite selfie/story for a chance to score one of three $500 gift cards. So vote now, we’re rooting for you!

In the meantime, it’s time to take action!  Visit a dermatologist today to ask if any of these clinically proven prescription treatments may be right for you:

-SOOLANTRA® (ivermectin) Cream, 1% is a once-daily, prescription topical treatment for the inflammatory lesions of rosacea. Soolantra Cream may start working as quickly as week two, with continuous improvement with long-term use.

-MIRVASO® (brimonidine) topical gel, 0.33%* is the first and only prescription treatment specifically developed and indicated to treat the persistent facial redness of rosacea. Apply Mirvaso Gel to your face once daily and it may start working in as little as 30 minutes. Mirvaso Gel won’t just cover up redness, it may reduce redness for up to 12 hours.

-ORACEA® (doxycycline, USP) 40 mg Capsules* are the one and only pill approved by the FDA for the treatment of the bumps and pimples of rosacea. Oracea Capsules work from within to target and treat the inflammatory lesions of rosacea in adults.

Struggling with redness, bumps and pimples on your face can make you feel uncomfortable in your own skin. Let’s stop layering on thick makeup because it doesn’t make the issue go away; it only covers it up.

Rock it like a Redhead!

Important Safety Information – Soolantra® Cream
Indication: SOOLANTRA (ivermectin) Cream, 1%, is indicated for the treatment of inflammatory lesions of rosacea. Adverse Events: In clinical trials with SOOLANTRA® Cream, the most common adverse reactions (incidence ≥ 1 %) included skin burning sensation and skin irritation. Warnings / Precautions: Not for oral, ophthalmic or intravaginal use.
Important Safety Information – Mirvaso® Gel
Indication: Mirvaso® (brimonidine) topical gel, 0.33% is an alpha-2 adrenergic agonist indicated for the topical treatment of persistent (nontransient) facial erythema of rosacea in adults 18 years of age or older. Adverse Events: In clinical trials, the most common adverse reactions (≥1%) included erythema, flushing, skin-burning sensation and contact dermatitis. Warnings/Precautions: Mirvaso Gel should be used with caution in patients with depression, cerebral or coronary insufficiency, Raynaud’s phenomenon, orthostatic hypotension, thromboangiitis obliterans, scleroderma, or Sjögren’s syndrome. Alpha-2 adrenergic agents can lower blood pressure. MIRVASO Gel should be used with caution in patients with severe or unstable or uncontrolled cardiovascular disease. Serious adverse reactions following accidental ingestion of Mirvaso Gel by children have been reported. Keep Mirvaso Gel out of reach of children. Not for oral, ophthalmic, or intravaginal use.
*Each gram of gel contains 5 mg of brimonidine tartrate, equivalent to 3.3 mg of brimonidine free base.
Important Safety Information – ORACEA®
Indication: ORACEA® (doxycycline, USP) Capsules 40 mg is indicated for the treatment of only inflammatory lesions (papules and pustules) of rosacea in adult patients. Adverse Events: In controlled clinical studies, the most commonly reported adverse events (>2%) in patients treated with ORACEA were nasopharyngitis, sinusitis, diarrhea, hypertension and aspartate aminotransferase increase. Warnings/Precautions: ORACEA should not be used to treat or prevent infections. ORACEA should not be taken by patients who have a known hypersensitivity to doxycycline or other tetracyclines. ORACEA should not be taken during pregnancy, by nursing mothers, or during tooth development (up to the age of 8 years). Although photosensitivity was not observed in clinical trials, ORACEA patients should minimize or avoid exposure to natural or artificial sunlight. The efficacy of ORACEA treatment beyond 16 weeks and safety beyond 9 months have not been established.
*30 mg Immediate Release and 10 mg Delayed Release Beads
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
All trademarks are the property of their respective owners.
I’m participating in the Break Up with Your Makeup contest sponsored by Galderma Laboratories, L.P.  You should discuss any medications with your doctor.